Interestingly, DAPK1 Knockdown or inhibition significantly suppressed the growth of the HCC1143, HCC1937, HCC1954 triple-negative breast cancer (TNBC) cell lines by 80–90% suggesting the development of DAPK1 inhibitors to target TNBC.24 Here, DAPK1 is linked to triple-negative breast carcinoma.